Former U.S. Rep. Curt Weldon does the biotech thing

I know. You were wondering just now what Curt Weldon is up to these days. Turns out, the former Delaware County congressman – who was ousted in 2006 amid a federal influence-peddling probe that never resulted in any charges but apparently got me yapping on wiretapped phones – is now in the biotech biz.

According to a press release that went out today, Weldon is representing New Jersey-based Regenicin, Inc. at The Future of Financial Markets Leadership Summit in Mumbai, an invitation-only event "attended by 400 of India's premier financial and investment leaders." From the release:

"This conference provides an opportunity for Curt to speak passionately about Regenicin and the company's role in bringing new breakthroughs in regenerative medicine to market," says Regenicin's CEO, Randall McCoy, who recently contracted the former Congressman as a business development consultant for the company. "It also provides the perfect forum for Curt to explore business development and investment opportunities for Regenicin in the global market."

Regenicin is a biotechnology company "specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs."

Reading this, I couldn't help but recall that Weldon once went to bat for another biotech company after 9/11 ... when he was a congressman ... and his fundraiser was a lobbyist for the company. But that was a long time ago.